Salesforce.com 2015 Annual Report Download - page 108

Download and view the complete annual report

Please find page 108 of the 2015 Salesforce.com annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 134

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134

stock that remained available for grant under the 2006 Inducement Equity Incentive Plan (the “Prior Inducement
Plan”) as of July 9, 2014 were added to the 2014 Inducement Plan share reserve and the Prior Inducement Plan
was terminated. Further, any shares of common stock subject to outstanding awards under the Prior Inducement
Plan that expire, are forfeited, or are repurchased by the Company will also become available for future grant
under the 2014 Inducement Plan. Termination of the Prior Inducement Plan did not affect the outstanding awards
previously issued thereunder. The 2014 Inducement Plan was adopted without stockholder approval in reliance
on the “employment inducement exemption” provided under the New York Stock Exchange Listed Company
Manual.
In September 2011, the Company’s Board of Directors amended and restated the ESPP. In conjunction with
the amendment of the ESPP, the Company’s Board of Directors determined that the offerings under the ESPP
would commence, beginning with a twelve month offering period starting in December 2011. As of January 31,
2015, $28.7 million has been withheld on behalf of employees for future purchases under the ESPP and is
recorded in accounts payable, accrued expenses and other liabilities. Employees purchased 3.3 million shares for
$127.8 million and 2.9 million shares for $92.5 million, in fiscal 2015 and 2014, respectively, under the ESPP.
Prior to February 1, 2006, options issued under the Company’s stock option plans generally had a term of 10
years. From February 1, 2006 through July 3, 2013, options issued had a term of five years. After July 3, 2013,
options issued have a term of seven years.
Stock activity excluding the ESPP is as follows:
Options Outstanding
Shares
Available
for Grant
Outstanding
Stock
Options
Weighted-
Average
Exercise Price
Aggregate
Intrinsic Value
(in thousands)
Balance as of January 31, 2014 ...... 55,852,536 28,604,045 $34.26
Increase in shares authorized:
2013 Equity Incentive
Plan .................. 3,943,052 0 0.00
2014 Inducement Equity
Incentive Plan .......... 1,007,381 0 0.00
2011 Relate IQ Plan ....... 291,361 0 0.00
Options granted under all plans . . (9,506,412) 9,506,412 57.87
Restricted stock activity ........ (18,781,110) 0 0.00
Stock grants to board and
advisory board members ...... (226,883) 0 0.00
Exercised ................... 0 (7,307,213) 24.17
Plan shares expired ............ (3,135,270) 0 0.00
Canceled .................... 1,344,883 (1,344,883) 34.80
Balance as of January 31, 2015 ...... 30,789,538 29,458,361 $44.36 $379,380,854
Vested or expected to vest .......... 27,308,293 $43.65 $369,299,016
Exercisable as of January 31, 2015 . . . 11,253,182 $34.37 $248,524,393
The total intrinsic value of the options exercised during fiscal 2015, 2014 and 2013 was $250.3 million,
$292.3 million and $506.9 million, respectively. The intrinsic value is the difference between the current market
value of the stock and the exercise price of the stock option.
The weighted-average remaining contractual life of vested and expected to vest options is approximately 4.3
years.
102